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Introduction {#sec001}
============

Fungal signaling pathways are critical for environmental interactions and survival. The yeast *Candida albicans* colonizes diverse biotic and abiotic surfaces in the human host and causes superficial and life-threatening infections in immunocompromised patients \[[@pgen.1008908.ref001], [@pgen.1008908.ref002]\]. *C*. *albicans* encounters rapidly changing microenvironments caused by fluctuating pH, temperature, osmolarity, O~2~ depletion, resident microbiota, host innate defenses, and antifungal drugs \[[@pgen.1008908.ref003]\]. These conditions all modulate the cell wall. As a fungal-specific structure, the cell wall is required for adhesion, morphogenesis, and resistance to plasma membrane turgor pressure \[[@pgen.1008908.ref004]\]. Transcription factors are a critical component of signaling pathways, as they control genes involved in developmental processes, stress adaptation, and pathogenesis. An understanding of cell wall signaling mechanisms at the transcriptional level can identify prospective genes, which can be valuable in developing antifungal interventions.

The echinocandin class of antifungal drugs causes cell lysis by inhibiting β-1-3 glucan synthesis \[[@pgen.1008908.ref005]\]. *C*. *albicans* executes a robust transcriptional program in response to cell wall damage (CWD) caused by the echinocandin caspofungin \[[@pgen.1008908.ref006]--[@pgen.1008908.ref008]\]. To date, the transcription factors Cas5, Rlm1, and Sko1 have been shown to mediate caspofungin-induced cell wall stress signaling. Deletion of *CAS5* results in hypersensitivity to various cell wall and plasma membrane perturbants and abrogates pathogenicity *in vivo* \[[@pgen.1008908.ref007], [@pgen.1008908.ref009], [@pgen.1008908.ref010]\]. Cas5 is dephosphorylated by Glc7 in response to CWD and regulates gene classes whose functions include cell wall biogenesis and integrity and cell cycle control \[[@pgen.1008908.ref008]\]. Although Cas5 is a major regulator of CWD response in *C*. *albicans*, Cas5 does not contain a homolog in the model yeast *Saccharomyces cerevisiae*.

Rlm1 is the key transcriptional regulator of CWD signaling in *S*. *cerevisiae* and is a downstream target of the Protein Kinase C (PKC) mitogen-activated protein kinase (MAPK) signaling pathway \[[@pgen.1008908.ref011]\]. In *C*. *albicans*, an *rlm1Δ/Δ* mutant strain is hypersensitive to caspofungin and shows reduced virulence in murine infection models \[[@pgen.1008908.ref007], [@pgen.1008908.ref012]\]. Despite this, Rlm1 was shown to regulate a small fraction of caspofungin-responsive genes, and its activators remain unknown \[[@pgen.1008908.ref007]\]. Recently, Rlm1 was shown to play a role in cell wall remodeling and filamentation in *C*. *albicans* when yeast-form cells were grown in lactate as a carbon source \[[@pgen.1008908.ref013]\].

Sko1 function has been extensively characterized in *S*. *cerevisiae*. In response to osmotic stress, Sko1 mediates adaptation via the MAPK signaling cascade known as the High Osmolarity Glycerol (HOG) pathway \[[@pgen.1008908.ref014]\]. Sko1 is phosphorylated by the MAP kinase Hog1 to both activate and repress its target genes \[[@pgen.1008908.ref015]\]. Prior gene expression and biochemical analyses revealed that Sko1 is conserved as a regulator of osmotic stress signaling in *C*. *albicans*, but there is considerable divergence in its target genes \[[@pgen.1008908.ref006], [@pgen.1008908.ref016]\]. Sko1 regulation of the CWD response is independent of HOG pathway signaling and requires the glucose-partitioning kinase Psk1 \[[@pgen.1008908.ref006]\]. Both *sko1*Δ/Δ and *psk1*Δ/Δ mutant strains are hypersensitive to caspofungin. Sko1 also regulates hypoxic and oxidative stress signaling and hyphal formation \[[@pgen.1008908.ref017], [@pgen.1008908.ref018]\]. The diverse processes controlled by Sko1, Rlm1, and Cas5 underscore their versatility and importance in *C*. *albicans* biology.

Here we have utilized molecular and cellular approaches to characterize the Sko1 and Rlm1 CWD signaling circuit. We identify new gene classes and biological processes that are regulated by Sko1 and Rlm1. Finally, we demonstrate the interconnected relationship between Sko1 and Rlm1 to coordinate the CWD response.

Results {#sec002}
=======

Regulation of *SKO1* transcription by Rlm1 {#sec003}
------------------------------------------

*SKO1* transcription is significantly upregulated in a Psk1-dependent manner following caspofungin exposure \[[@pgen.1008908.ref006]\], but a direct activator of Sko1 has not yet been identified. Microarray analysis has previously reported that Rlm1 partially controls *SKO1* transcription in nutrient-rich medium \[[@pgen.1008908.ref012]\]; however, it is unknown whether Rlm1 controls *SKO1* transcription in response to CWD. We hypothesized that caspofungin-induced *SKO1* expression may require Rlm1 and/or Cas5. We considered Cas5 because it is the only other known regulator of caspofungin-induced signaling, and *SKO1* was not included in the microarray dataset of a *cas5Δ/Δ* mutant strain treated with caspofungin \[[@pgen.1008908.ref007]\]. We performed RT-qPCR to measure S*KO1* transcript levels in wild-type, *cas5Δ/Δ* mutant, and *rlm1Δ/Δ* mutant strains. As was previously observed \[[@pgen.1008908.ref006]\], *SKO1* expression significantly increased following caspofungin treatment in wild-type cells ([Fig 1A](#pgen.1008908.g001){ref-type="fig"}). *SKO1* expression was relatively unchanged in the *cas5Δ/Δ* mutant strain under basal conditions and was slightly greater following caspofungin treatment compared to the wild-type strain; however, this increase was not significant. This finding establishes that *SKO1* is not a downstream target of Cas5.

![RT-qPCR analysis of *SKO1* expression in transcription factor mutants.\
A) *SKO1* expression was measured in the wild-type strain (WT), *cas5Δ/Δ* mutant strain, and *rlm1Δ/Δ* mutant strain. All strains were treated with 125 ng/mL caspofungin or dH~2~O (control) for 30 min. Transcript levels were normalized to *TDH3* (which encodes glyceraldehyde-3-phosphate dehydrogenase) expression, and fold changes were normalized to the untreated wild-type strain adjusted to the value of 1.0. B) *SKO1* expression was measured in the wild-type strain, *rlm1Δ/Δ* mutant strain, and *rlm1Δ/Δ/RLM1* complemented strain, and fold changes were normalized to the caspofungin-treated wild-type strain adjusted to the value of 1.0. Data presented represents the mean of three biological replicates. The asterisk indicates a *P-*value of ≤ 0.05 between the wild-type and *rlm1Δ/Δ* mutant strains.](pgen.1008908.g001){#pgen.1008908.g001}

Strikingly, *SKO1* expression was significantly reduced in the *rlm1Δ/Δ* mutant strain treated with caspofungin ([Fig 1A](#pgen.1008908.g001){ref-type="fig"}) and, in concordance with previous microarray experiments, slightly reduced in the untreated *rlm1Δ/Δ* mutant strain ([Fig 1A](#pgen.1008908.g001){ref-type="fig"}, \[[@pgen.1008908.ref012]\]). To confirm that this phenotype was due to the loss of Rlm1 function, we measured *SKO1* expression in an *rlm1Δ/Δ/RLM1* complemented strain following caspofungin treatment. Our findings show that reintroduction of a single *RLM1* allele in the *rlm1Δ/Δ* mutant strain is sufficient to restore *SKO1* expression to wild-type levels ([Fig 1B](#pgen.1008908.g001){ref-type="fig"}). Taken together, our gene expression findings show that Rlm1 partially controls caspofungin-induced *SKO1* expression.

The connection between *SKO1* and *RLM1* implicates an expanded role for Rlm1 in caspofungin-induced cell wall signaling than previously reported \[[@pgen.1008908.ref007]\]. If Rlm1 controls CWD signaling in part by activating *SKO1*, we then reasoned that known Sko1-dependent CWD genes must also require Rlm1 for full expression. We measured the expression of *PHR2*, *KRE9*, *KRE1*, *MNN2*, and *SKN1* in *rlm1Δ/Δ* mutant cells following caspofungin treatment. These genes were chosen based on their known cell wall functions \[[@pgen.1008908.ref019]\]. Also, previous microarray and RT-qPCR results showed significantly reduced transcription of these genes in the *sko1Δ/Δ* mutant strain following caspofungin treatment \[[@pgen.1008908.ref006]\]. Our RT-qPCR results show that expression of these genes was reduced at least 1.5 fold in the *rlm1Δ/Δ* mutant strain compared to the wild-type strain ([Fig 2](#pgen.1008908.g002){ref-type="fig"}). Therefore, Rlm1 also partially controls Sko1-dependent genes in CWD signaling.

![RT-qPCR analysis of Sko1-regulated caspofungin-responsive genes.\
Gene expression was monitored in *C*. *albicans* wild-type and *rlm1Δ/Δ* mutant strains following 30 minutes of 125 ng/mL caspofungin treatment. Data presented represents the mean of three biological replicates. Transcript levels were normalized to *TDH3* expression, and fold changes between strains were normalized to the wild-type reference strain adjusted to a value of 1.0. The asterisk indicates a *P-*value of ≤ 0.05 between the wild-type and *rlm1Δ/Δ* mutant strains.](pgen.1008908.g002){#pgen.1008908.g002}

Identification of Rlm1 direct gene targets {#sec004}
------------------------------------------

Although previous microarray analysis showed that Rlm1 only regulated two caspofungin-induced genes \[[@pgen.1008908.ref007]\], our RT-qPCR results indicate that Rlm1 regulates additional CWD response genes (Figs [1](#pgen.1008908.g001){ref-type="fig"} and [2](#pgen.1008908.g002){ref-type="fig"}). It is unknown, however, whether these genes are direct targets of Rlm1. To address this, we performed genome-wide ChIP-seq experiments to identify direct Rlm1 target genes. We analyzed Rlm1 upstream intergenic region enrichment in the presence or absence of caspofungin using a wild-type strain containing an Rlm1-V5 tagged protein. We found Rlm1 enrichment at a total of 30 gene upstream intergenic regions. Of these, 5 are potential false positives due to their association with genomic regions that are highly enriched in ChIP-seq experiments irrespective of antibody specificity \[[@pgen.1008908.ref020]\]; these 5 genes were excluded from further analyses. We observed upstream intergenic region enrichment for 18 genes in response to caspofungin and 4 genes under untreated conditions. 3 genes showed equal levels of upstream intergenic region enrichment under both conditions ([S1 Appendix](#pgen.1008908.s006){ref-type="supplementary-material"} and [S2 Table](#pgen.1008908.s002){ref-type="supplementary-material"}).

Interestingly, Rlm1 directly bound to the upstream intergenic regions of key cell wall integrity genes including *PGA59*, *PGA56*, and *PGA62*, as well as the cell wall glycosidase-encoding gene, *PHR2* ([Fig 3A and 3B](#pgen.1008908.g003){ref-type="fig"} and [S1 Appendix](#pgen.1008908.s006){ref-type="supplementary-material"}). *PHR2* is significantly upregulated in response to caspofungin \[[@pgen.1008908.ref007]\]. However, in that study, *PHR2* did not require Rlm1 for full expression. Also, strains containing mutations to the *PHR2* paralogous gene, *PHR1*, were found to be hypersensitive to caspofungin \[[@pgen.1008908.ref021]\]. Although we show that Rlm1 controls transcription of *SKO1* and Sko1-dependent CWD genes (Figs [1](#pgen.1008908.g001){ref-type="fig"} and [2](#pgen.1008908.g002){ref-type="fig"}), we did not identify *SKO1* as a direct gene target of Rlm1. Therefore, based on our results, Rlm1 appears to be an indirect regulator of *SKO1* transcription.

![Identification of Rlm1 direct target genes via ChIP-seq.\
Wild-type cultures containing epitope-tagged Rlm1-V5 were treated with or without 125 ng/mL caspofungin for 30 minutes prior to immunoprecipitation. Immunoprecipitation was also conducted using untagged wild-type caspofungin-treated cells to examine non-specific binding with the anti-V5 antibody. The ChIP-seq binding data was mapped and plotted using MochiView and the Rlm1 target genes A) *ORF19*.*2766* and *PGA62*, B) *PHR2*, and C) *SHA3* are shown. Blue peaks correspond to caspofungin-treated Rlm1-V5 cells, and red peaks correspond to untreated Rlm1-V5 cells. The black dashed line represents untagged Rlm1 cells treated with caspofungin, and the grey dashed line represents untagged Rlm1 untreated cells. The X-axis represents 4000 bp ORF chromosomal locations, and the Y-axis represents enriched coverage compared to the expected average coverage. Genes (yellow boxes) plotted above the bold line are read in the sense direction, and genes below the line are read in the antisense direction. D) A 500 bp region around the top enriched binding targets was used to identify the binding motif recognized by Rlm1 using MEME and corroborated using MochiView. E-F) GO enrichment analyses for Biological Processes and Cellular Components (*P*-value \< 0.01) for all Rlm1 target genes are shown.](pgen.1008908.g003){#pgen.1008908.g003}

Next, we compared our Rlm1 ChIP-seq dataset against existing *C*. *albicans* Rlm1 microarray datasets to determine if Rlm1 directly binds to and regulates transcription of known downstream target genes. We identified two uncharacterized directly bound Rlm1 target genes, *ORF19*.*3698* and *ORF19*.*5322*, from our ChIP-seq dataset that were identified as differentially regulated in the absence of any stressors in the *rlm1Δ/Δ* microarray dataset from Delgado-Silva et al. \[[@pgen.1008908.ref012]\]. Surprisingly, we did not identify Rlm1 directly bound target genes that matched the Bruno et al. caspofungin microarray dataset \[[@pgen.1008908.ref007]\]. We note that our experiments were performed under similar growth conditions as both microarray experiments. Taken together, our ChIP-seq results reveal a new set of directly bound Rlm1-dependent target genes that were previously undetected by DNA microarrays.

We performed Cluster of Orthologous Groups (COG) and Gene Ontology (GO) analyses with our ChIP-seq dataset to annotate target genes and to identify new Rlm1 biological roles. We also utilized the Kyoto Encyclopedia of Genes and Genomes (KEGG) to identify pathways for Rlm1 target genes. COG analysis showed that uncharacterized genes accounted for the greatest percentage (32%) of Rlm1 direct gene targets ([S1 Fig](#pgen.1008908.s003){ref-type="supplementary-material"} and [S2 Table](#pgen.1008908.s002){ref-type="supplementary-material"}). Other important categories included intracellular trafficking (8%), and translation (8%). GO enrichment for the cellular component category showed that several Rlm1 direct target genes encode for proteins that localize to cytoskeletal sites such as microtubules and the spindle pole ([Fig 3F](#pgen.1008908.g003){ref-type="fig"}). GO enrichment for the biological processes category implicated Rlm1 in protein and organelle localization and secretion ([Fig 3E](#pgen.1008908.g003){ref-type="fig"}). Notable direct gene targets include the secretory vesicle component-encoding gene *SEC10* ([S1 Appendix](#pgen.1008908.s006){ref-type="supplementary-material"}), and the glucose sensor-encoding gene, *SHA3* ([Fig 3C](#pgen.1008908.g003){ref-type="fig"}). KEGG analysis did not identify any pathways associated with Rlm1 direct target genes. Taken together, our results identify a new class of Rlm1 dependent caspofungin-responsive directly bound target genes including genes with functions in cell wall integrity. Furthermore, we identify a potential role for Rlm1 in regulating molecular localization and secretion.

Identification of Sko1 direct gene targets {#sec005}
------------------------------------------

Previous microarray and RT-qPCR gene expression analyses showed that Sko1 regulates the transcription of 26 caspofungin-induced genes \[[@pgen.1008908.ref006]\]. We performed ChIP-seq analysis to identify Sko1 direct target genes. Similar to our Rlm1 experiments, we utilized a wild-type strain containing a Sko1-V5 tagged protein \[[@pgen.1008908.ref006]\] to determine Sko1 upstream intergenic region enrichment in the presence or absence of caspofungin. We found Sko1 enrichment at 108 gene upstream intergenic regions, of which 21 were potential false positives (based on \[[@pgen.1008908.ref020]\]) and thus excluded from further analyses ([S2 Appendix](#pgen.1008908.s007){ref-type="supplementary-material"} and [S2 Table](#pgen.1008908.s002){ref-type="supplementary-material"}). We observed enhanced upstream intergenic region enrichment for 85 genes in response to caspofungin and for one gene under basal conditions ([S2 Appendix](#pgen.1008908.s007){ref-type="supplementary-material"} and [S2 Table](#pgen.1008908.s002){ref-type="supplementary-material"}). Interestingly, we found that Sko1 was enriched at its own upstream intergenic region and shows higher levels of enrichment during caspofungin treatment ([Fig 4G](#pgen.1008908.g004){ref-type="fig"} and [S2 Appendix](#pgen.1008908.s007){ref-type="supplementary-material"}). In addition, Sko1 appears to bind across its own ORF irrespective of caspofungin treatment ([Fig 4G](#pgen.1008908.g004){ref-type="fig"} and [S2 Appendix](#pgen.1008908.s007){ref-type="supplementary-material"}). Although the basis of this binding is unclear, one possibility is that Sko1 is involved in activating transcription elongation. Alternatively, Sko1 ORF binding could be due to an artifact of the ChIP-seq procedure, which has been observed to occur for genes that are highly actively transcribed \[[@pgen.1008908.ref022]\]. Based on these findings, *SKO1* transcription may be, at least partly, dependent on self-activation.

![Identification of Sko1 direct target genes via ChIP-seq.\
Wild-type cultures containing epitope-tagged Sko1-V5 were treated with or without 125 ng/mL caspofungin for 30 minutes prior to immunoprecipitation. Immunoprecipitation was also conducted using untagged wild-type caspofungin-treated cells to examine non-specific binding with the anti-V5 antibody. The ChIP-seq binding data was mapped and plotted using MochiView and the Sko1 gene targets A) *ALS1*, B) *MNN21*, C) *SSA2*, D) *PGA31*, E) *PTP2*, F) *ENA21*, G) *SKO1*, and H) *RHR2* are shown. Blue peaks correspond to caspofungin-treated Sko1-V5 cells, and red peaks correspond to untreated Sko1-V5 cells. The black dashed line represents untagged Sko1 cells treated with caspofungin, and the grey dashed line represents untagged Sko1 untreated cells. The X-axis represents 4000 bp ORF chromosomal locations, and the Y-axis represents enriched coverage compared to the expected average coverage. Genes (yellow boxes) plotted above the bold line are read in the sense direction, and genes below the line are read in the antisense direction. I) A 500 bp region around the top enriched binding targets was used to identify the binding motif recognized by Sko1 using MEME and corroborated using MochiView. J-K) GO enrichment analyses for Molecular Functions and Biological Processes (*P*-value \< 0.01) for all Sko1 target genes are shown.](pgen.1008908.g004){#pgen.1008908.g004}

We compared our Sko1 ChIP-seq dataset against existing microarray datasets examining transcriptional changes in the *sko1Δ/Δ* mutant strain exposed to caspofungin \[[@pgen.1008908.ref006]\] or sodium chloride \[[@pgen.1008908.ref016]\] to assess whether Sko1 direct binding modulates transcription. We included the sodium chloride dataset because osmotic stress causes cell wall remodeling \[[@pgen.1008908.ref023]\]. We identified a total of 30 genes from our ChIP-seq data that were previously shown to be regulated by Sko1 ([S2 Table](#pgen.1008908.s002){ref-type="supplementary-material"}). Specifically, in response to caspofungin, we identified 6 known Sko1 caspofungin-induced genes (out of the 26 caspofungin-induced gene targets identified in previous microarrays), including *PGA31* ([Fig 4D](#pgen.1008908.g004){ref-type="fig"}), and 13 known Sko1 caspofungin-repressed genes ([S2 Table](#pgen.1008908.s002){ref-type="supplementary-material"}). We identified 17 Sko1-activated genes and 4 Sko1-repressed genes in response to osmotic stress, including the alcohol dehydrogenase-encoding gene, *ADH1* ([S2 Table](#pgen.1008908.s002){ref-type="supplementary-material"}), and the glycerol metabolic enzyme-encoding genes, *RHR2* ([Fig 4H](#pgen.1008908.g004){ref-type="fig"}) and *GPD2* ([S2 Table](#pgen.1008908.s002){ref-type="supplementary-material"}). Collectively, these results demonstrate that Sko1 directly binds to and regulates a group of major stress response genes.

Because the majority of Sko1 directly bound target genes were not identified in previous *sko1Δ/Δ* microarrays, we performed COG, GO, and KEGG analyses to gain insight into the physiological and molecular roles of Sko1 target genes. COG analysis revealed the majority of Sko1 target genes (17%) were uncharacterized. Major categories for Sko1 target genes include signal transduction (7%), post-translational modification (7%), carbohydrate transport and metabolism (7%), intracellular trafficking and secretion (3%), and transcription (6%) ([S1 Fig](#pgen.1008908.s003){ref-type="supplementary-material"} and [S2 Table](#pgen.1008908.s002){ref-type="supplementary-material"}).

Our GO enrichment findings for biological processes revealed that Sko1 regulates osmotic stress response target genes upon caspofungin treatment ([Fig 4K](#pgen.1008908.g004){ref-type="fig"}). Notable target genes include the sodium transporter-encoding gene, *ENA21* ([Fig 4F](#pgen.1008908.g004){ref-type="fig"}), and the HOG pathway two-component phosphotransferase regulator-encoding gene, *YPD1* ([S2 Appendix](#pgen.1008908.s007){ref-type="supplementary-material"}). GO enrichment findings for the molecular functions category highlighted genes associated with protein kinase binding ([Fig 4J](#pgen.1008908.g004){ref-type="fig"}). We did not find any enrichment for the cellular localization category. KEGG analysis identified several Sko1 targets that are essential in regulating MAPK stress signaling pathways including the phosphatase-encoding gene, *PTP2* ([Fig 4E](#pgen.1008908.g004){ref-type="fig"} and [S3 Fig](#pgen.1008908.s005){ref-type="supplementary-material"}). Collectively, our ChIP-seq findings and computational analyses identify a new set of Sko1 target genes and reveal a new role for Sko1 in caspofungin-induced osmoregulation.

Identification of a Sko1 and Rlm1 DNA-binding consensus motif {#sec006}
-------------------------------------------------------------

Previous *in silico* analyses of our osmotic stress microarray dataset identified two putative Sko1 DNA binding motifs \[[@pgen.1008908.ref016]\]. The consensus motif, (A/T)ATAGCAAT(T/C)A, was identified for genes repressed by Sko1 and the motif, (T/C)TCATCTCATC(G/T)CA(A/T), for genes activated by Sko1. For Rlm1, *in silico* promoter analysis has not been performed on microarray datasets; however, Rlm1 target genes were previously screened for the presence of the *S*. *cerevisiae* Rlm1 binding motif CTAWWWWTAG \[[@pgen.1008908.ref012], [@pgen.1008908.ref024]\].

We utilized the motif-detecting software MEME and the Motif Finder function in MochiView to identify authentic Rlm1 and Sko1 DNA consensus motifs based on direct binding events from our ChIP-seq data. For Rlm1, we identified the consensus motif, CACCACCACAACC (*P* = 1.5e^-05^ and IC score of 19), and found that 1--8 instances of the motif occurred in the upstream intergenic regions of directly bound Rlm1 target genes ([Fig 3D](#pgen.1008908.g003){ref-type="fig"}, [S2 Table](#pgen.1008908.s002){ref-type="supplementary-material"}). Overall, the Rlm1 motif we identified was found approximately 2 times more frequently in the upstream intergenic regions of directly bound Rlm1 target genes compared to the frequency of finding it in intergenic regions of the entire *C*. *albicans* genome. Interestingly, the *C*. *albicans* consensus motif we identify here is distinct from that of the Rlm1 consensus motif identified in *S*. *cerevisiae*, indicating that the Rlm1 consensus binding motifs between these two fungal species are highly diverged. Although the function of Rlm1 in cell wall signaling is conserved in both species, this finding exemplifies the prevalence of transcriptional rewiring in *C*. *albicans*. Overall, our promoter analyses reveal a novel Rlm1 DNA-binding consensus motif for *C*. *albicans*.

For Sko1 target genes, we identified the consensus motif, CTATGACGTCAT (*P* = 2.9^e-20^ and IC score 18.2), from our ChIP-seq data, where 1--3 instances of the motif occurred in the upstream intergenic regions of directly bound Sko1 target genes ([Fig 4I](#pgen.1008908.g004){ref-type="fig"}, [S2 Table](#pgen.1008908.s002){ref-type="supplementary-material"}). Overall, the Sko1 motif was found approximately 4 times more frequently in Sko1 target genes compared to the frequency of finding it in intergenic regions of the entire *C*. *albicans* genome. Notably, the Sko1 consensus motif identified here by ChIP-seq bears some similarity to the motif for Sko1-activated genes previously identified by microarray studies. We utilized the Yeast Transcription Factor Specificity Compendium (YeTFaSCo) database \[[@pgen.1008908.ref025]\] to determine whether the *C*. *albicans* Sko1 motif was similar to known transcription factor DNA-binding motifs in *S*. *cerevisiae*. We found that our sequence partially matched the *S*. *cerevisiae* Sko1 ATF/CREB consensus motif, T(G/T)ACGT(C/A)A. This result indicates that the Sko1 DNA binding motif is likely conserved between *S*. *cerevisiae* and *C*. *albicans*.

*SKO1* suppression analyses {#sec007}
---------------------------

Overexpression suppression analyses can be used to determine if two functionally related genes are part of the same pathway \[[@pgen.1008908.ref026]\]. Since Rlm1 partially controls *SKO1* transcription and the expression of several Sko1 dependent genes (Figs [1](#pgen.1008908.g001){ref-type="fig"} and [2](#pgen.1008908.g002){ref-type="fig"}), we hypothesized that *SKO1* overexpression would suppress the caspofungin hypersensitivity phenotype of the *rlm1Δ/Δ* mutant strain. We overexpressed *SKO1* in an *rlm1Δ/Δ* mutant strain and a wild-type strain and monitored cell growth in the presence of caspofungin. To verify *SKO1* overexpression, we monitored transcription of the Sko1 and Rlm1 caspofungin-dependent genes *PGA13*, *PGA31*, and *CRH11* \[[@pgen.1008908.ref006], [@pgen.1008908.ref007]\] in the *P*~*TDH3*~*SKO1-rlm1Δ/Δ* overexpressing strain. *CRH11*, *PGA13*, and *PGA31* expression was significantly elevated in the *SKO1* overexpressing *rlm1Δ/Δ* mutant strain compared to the wild-type and *rlm1Δ/Δ* mutant strains ([S2 Fig](#pgen.1008908.s004){ref-type="supplementary-material"}). Thus, our *SKO1* overexpressing strain is functional and significantly increases transcription of *SKO1* and *RLM1* target genes.

Our spot plate growth assays showed that the *SKO1* overexpressing wild-type strain had no apparent phenotype under basal growth conditions or in the presence of caspofungin ([Fig 5A](#pgen.1008908.g005){ref-type="fig"}). The *rlm1Δ/Δ* mutant strain grew poorly in the presence of 50 ng/mL caspofungin, consistent with observations from previous studies \[[@pgen.1008908.ref007], [@pgen.1008908.ref012]\]. Strikingly, growth was partially restored in the *rlm1Δ/Δ* mutant strain overexpressing *SKO1* ([Fig 5A](#pgen.1008908.g005){ref-type="fig"}). In addition, our spot plate results were consistent with our microplate liquid kinetic growth assays ([Fig 5B](#pgen.1008908.g005){ref-type="fig"}). Collectively, these results, combined with our RT-qPCR results (Figs [1](#pgen.1008908.g001){ref-type="fig"} and [2](#pgen.1008908.g002){ref-type="fig"}), indicate that the Sko1 and Rlm1 cell wall stress signaling pathways are linked in *C*. *albicans*.

![Characterization of *SKO1* overexpression.\
Solid and liquid growth assay results of the wild-type strain, *rlm1Δ/Δ* mutant strain, *P*~*TDH3*~*SKO1* overexpressing strain, and *P*~*TDH3*~*SKO1-rlm1Δ/Δ* overexpressing strain. A) Overnight cultures were serially diluted onto nutrient YPD^uri^ plates supplemented with or without 50 ng/mL caspofungin. Plates were photographed following 48 hours of growth at 30°C. B) Growth kinetics were monitored in a microplate reader. Overnight cultures were standardized to an OD~600nm~ of 0.2 in 200 μL YPD^uri^ and incubated with water as a control or caspofungin. For each assay, three biological replicates were analyzed. Experiments were repeated two times, and data presented depicts one representative experiment. The line graph on the left represents untreated samples, and the graph on the right represents samples treated with 50 ng/mL caspofungin.](pgen.1008908.g005){#pgen.1008908.g005}

Role of glycerol metabolism in *SKO1* suppression {#sec008}
-------------------------------------------------

Glycerol metabolism is elevated in wild-type cells treated with caspofungin, presumably to counteract osmotic stress caused by CWD \[[@pgen.1008908.ref006], [@pgen.1008908.ref012], [@pgen.1008908.ref027], [@pgen.1008908.ref028]\]. We hypothesized that overexpression of *SKO1* alleviates caspofungin hypersensitivity in the *rlm1Δ/Δ* mutant strain in part by upregulating the glycerol synthesis gene, *RHR2*. We overexpressed *RHR2* in both *rlm1Δ/Δ* and *sko1Δ/Δ* mutant strains and examined growth in the presence of caspofungin. *RHR2* overexpression in the *sko1Δ/Δ* mutant strain partially rescued caspofungin hypersensitivity ([Fig 6A](#pgen.1008908.g006){ref-type="fig"}). This finding implies that in a *sko1Δ/Δ* mutant strain, CWD-induced osmotic stress contributes to caspofungin hypersensitivity. On the other hand, *RHR2* overexpression did not suppress caspofungin hypersensitivity in the *rlm1Δ/Δ* mutant strain ([Fig 6B](#pgen.1008908.g006){ref-type="fig"}). Thus, while *SKO1* overexpression is sufficient to suppress caspofungin hypersensitivity in the *rlm1Δ/Δ* mutant strain ([Fig 5](#pgen.1008908.g005){ref-type="fig"}), the mechanism governing this phenotype is independent of glycerol metabolism.

![Glycerol overproduction analysis.\
Growth assay results of the wild-type strain, *sko1Δ/Δ* mutant strain, *rlm1Δ/Δ* strain, *P*~*TDH3*~*RHR2-sko1Δ/Δ* overexpressing strain and *P*~*TDH3*~*RHR2-rlm1Δ/Δ* overexpressing strain. Overnight cultures were serially diluted onto nutrient YPD^uri^ plates supplemented with or without 50 ng/mL caspofungin. Plates were photographed following A) 48 and B) 24 hours of growth at 30°C. Images were cropped to exclude samples not relevant to this study.](pgen.1008908.g006){#pgen.1008908.g006}

Discussion {#sec009}
==========

Caspofungin is the premier echinocandin antifungal drug for combating invasive infections caused by *C*. *albicans* \[[@pgen.1008908.ref005]\]. Transcription factors Sko1, Rlm1, and Cas5 control the adaptive response to caspofungin-induced CWD. Although the molecular mechanisms governing Cas5 signaling have been characterized \[[@pgen.1008908.ref007], [@pgen.1008908.ref008]\], several key biological questions remain unanswered regarding Sko1 and Rlm1 function. Here, we show that the Sko1 and Rlm1 cell wall stress signaling pathways are interconnected and introduce a new set of Rlm1 and Sko1 directly bound downstream target genes, several of which, are uncharacterized in *C*. *albicans* ([Fig 7](#pgen.1008908.g007){ref-type="fig"}). Our findings define the Sko1 and Rlm1 genetic response to caspofungin-induced cell wall stress and underscore the importance of signal rewiring and pathway redundancy to fine-tune the adaptive response to CWD in *C*. *albicans*.

![Rlm1/Sko1 cell wall damage signaling.\
Following caspofungin treatment (lightning symbol), Rlm1 and Sko1 regulate diverse gene classes (boxed) to restore cell wall integrity. Gene classes identified using GO enrichment are in black font, and gene classes identified using COG analysis are in red font. Increased *SKO1* expression occurs directly through Sko1 self-activation (bent solid arrow). Rlm1 indirectly activates *SKO1* transcription by an unknown post-translational mechanism (dashed blue arrow).](pgen.1008908.g007){#pgen.1008908.g007}

Crosstalk between Sko1 and Rlm1 cell wall signaling {#sec010}
---------------------------------------------------

A major goal motivating this study was to determine the regulatory mechanisms underlying Sko1 activation of CWD signaling. Our gene expression and phenotypic suppression findings demonstrate that Rlm1 regulates *C*. *albicans* caspofungin-induced CWD signaling in part through the activation of Sko1 signaling. Four major lines of evidence support this hypothesis: (i) *SKO1* caspofungin-induced expression is reduced over 5-fold in an *rlm1Δ/Δ* mutant strain ([Fig 1](#pgen.1008908.g001){ref-type="fig"}); (ii) several Sko1-specific caspofungin-response genes showed reduced expression in an *rlm1Δ/Δ* mutant strain ([Fig 2](#pgen.1008908.g002){ref-type="fig"}); (iii) *SKO1* overexpression specifically alleviated caspofungin hypersensitivity in an *rlm1Δ/Δ* mutant strain ([Fig 5](#pgen.1008908.g005){ref-type="fig"}); and (iv) prior gene expression results showed that Rlm1 activates *SKO1* transcription in the absence of caspofungin treatment \[[@pgen.1008908.ref012]\]. In *S*. *cerevisiae*, the PKC and HOG MAP kinase pathways coordinate CWD signaling following exposure to the β-1-3 glucanase, zymolyase. Rlm1, but not Sko1, is required to mount the transcriptional response to zymolyase \[[@pgen.1008908.ref029]\]. Thus, the Rlm1-Sko1 connection represents a new paradigm in transcriptional regulation of CWD in *C*. *albicans*.

Role of Rlm1 direct gene targets {#sec011}
--------------------------------

The cellular and molecular bases of caspofungin hypersensitivity for cell wall transcriptional regulators has been enigmatic, where multiple diverse biological processes are known to be affected by CWD, thus leading to presumable pleiotropic effects \[[@pgen.1008908.ref006]--[@pgen.1008908.ref008]\]. Following caspofungin stress, a previous gene expression microarray study found that Rlm1 modulated the expression of only 5 genes, with two genes (C*RH11* and *PGA13*), being necessary for cell wall integrity \[[@pgen.1008908.ref007]\]. Although the *pga13Δ/Δ* and *crh11Δ/Δ* mutants are hypersensitive to several cell wall perturbants \[[@pgen.1008908.ref030], [@pgen.1008908.ref031]\], *pga13Δ/Δ* is only slightly sensitive to caspofungin \[[@pgen.1008908.ref006]\]. Further, *PGA13* and *CRH11* are upregulated by Sko1 and Cas5 \[[@pgen.1008908.ref006], [@pgen.1008908.ref007]\]. Taken together, it seems likely that other factors contribute to caspofungin hypersensitivity. Another previous gene expression microarray study in the absence of caspofungin treatment found that the *rlm1Δ/Δ* mutant strain had altered expression of 773 genes (including several transcriptional regulators, *SKO1*, and Sko1-dependent genes) \[[@pgen.1008908.ref012]\]. Therefore, the simplest explanation for the caspofungin hypersensitivity of the *rlm1Δ/Δ* mutant strain is that the mutant is unable to activate Sko1 signaling. Our gene expression and growth suppression results support this hypothesis (Figs [1](#pgen.1008908.g001){ref-type="fig"}, [2](#pgen.1008908.g002){ref-type="fig"} and [5](#pgen.1008908.g005){ref-type="fig"}). We further addressed this hypothesis by performing genome-wide ChIP-seq experiments.

Our ChIP-seq dataset identified 25 Rlm1 direct target genes, which did not include *SKO1* or any known transcriptional regulator ([S1 Appendix](#pgen.1008908.s006){ref-type="supplementary-material"} and [S2 Table](#pgen.1008908.s002){ref-type="supplementary-material"}). Only two uncharacterized genes from our ChIP-seq dataset were previously identified by Rlm1 microarray experiments \[[@pgen.1008908.ref012]\], highlighting the relevance of ChIP-seq experiments to study gene regulation. We examined the amino acid sequence of all 25 proteins encoded by these target genes \[[@pgen.1008908.ref019]\] for the presence of a putative DNA-binding domain but failed to identify any candidates. Our upstream intergenic region analyses of the Rlm1 target genes identified a novel *C*. *albicans* Rlm1 binding consensus motif, CACCACCACAACC. While we find that Rlm1 does not directly regulate Sko1 or another transcription factor, our results identify a new class of direct Rlm1 target genes that could be important players in the CWD response.

Our COG analysis shows that most Rlm1 target genes are uncharacterized ([S1 Fig](#pgen.1008908.s003){ref-type="supplementary-material"}). However, Rlm1 localizes to the upstream intergenic regions of four key cell wall genes: *PGA56*, *PGA59*, *PGA62*, and *PHR2* ([Fig 3A and 3B](#pgen.1008908.g003){ref-type="fig"} and [S1 Appendix](#pgen.1008908.s006){ref-type="supplementary-material"}). Similar to the *rlm1Δ/Δ* mutant strain, *pga59Δ/Δ*, *pga62Δ/Δ*, and *phr2Δ/Δ* mutant strains are sensitive to cell wall perturbants and contain increased levels of chitin in their cell walls \[[@pgen.1008908.ref032], [@pgen.1008908.ref033]\]. Increased chitin synthesis is characteristic of a possible compensatory mechanism to maintain cell wall integrity \[[@pgen.1008908.ref034]\] and occasionally confers caspofungin resistance as observed with the *pga62Δ/Δ* mutant strain \[[@pgen.1008908.ref021], [@pgen.1008908.ref032]\]. We argue that the attenuated regulation of *PGA59*, *PGA62*, and *PHR2* could lead to reduced integrity of the *rlm1Δ/Δ* mutant cell wall.

Our GO biological process and cellular component enrichment category results indicate that Rlm1 regulates macromolecular and organelle localization, where several Rlm1-dependent target genes are predicted to associate with microtubules. Notable genes include two essential genes: *SEC10* and *SHA3*. *SEC10* encodes a protein that is a component of the highly conserved exocyst complex, which mediates polarized secretion \[[@pgen.1008908.ref035], [@pgen.1008908.ref036]\]. In *S*. *cerevisiae*, the Rlm1 regulator Slt2 is required for polarized cell growth \[[@pgen.1008908.ref037], [@pgen.1008908.ref038]\]; however, it is unknown whether Slt2 mediates cell growth via Rlm1. Our findings reveal a potential new role for Rlm1 function in *S*. *cerevisiae*. *SHA3* encodes a kinase involved in glucose transport and sensing \[[@pgen.1008908.ref036], [@pgen.1008908.ref039]\]. Further, a *sha3Δ/SHA3* heterozygous mutant displays altered colony morphology. The cell wall is primarily composed of carbohydrates, and thus interruption of Sha3 and Sec10 function may have profound consequences for biological processes requiring cell wall function.

Context-dependent Sko1 control of cell wall-induced osmotic stress {#sec012}
------------------------------------------------------------------

Transcriptional networks in *C*. *albicans* display a high level of redundancy where multiple transcription factors can regulate one another as well as overlapping sets of target genes \[[@pgen.1008908.ref017], [@pgen.1008908.ref040]\]. Consequently, it is often difficult to determine the contributions of each individual transcriptional regulator in an adaptive response that is mediated by multiple regulators within a complex transcriptional network. We employed genome-wide ChIP-seq to define the individual role of Sko1 in CWD signaling. From these results, we identified 87 direct Sko1 target genes ([S2 Appendix](#pgen.1008908.s007){ref-type="supplementary-material"}). Our upstream intergenic region analyses of the Sko1 target genes identified the consensus motif, CTATGACGTCAT for *C*. *albicans* Sko1. This sequence is similar to the canonical *S*. *cerevisiae* Sko1 ATF/CREB motif \[[@pgen.1008908.ref014]\], highlighting conserved aspects of Sko1 function in *C*. *albicans*.

Similar to Rlm1, our COG analysis revealed that the majority of Sko1 target genes are uncharacterized. Our GO enrichment and KEGG analyses, however, revealed that a subset of the Sko1 target genes is required for the osmotic stress response. Major "hallmark" genes for this response include *SOU1*, *ENA21*, *YPD1*, *GPD2*, *RHR2*, and *HGT19* ([Fig 4](#pgen.1008908.g004){ref-type="fig"} and [S2 Appendix](#pgen.1008908.s007){ref-type="supplementary-material"}); these genes are significantly upregulated in wild-type strains following NaCl treatment and are regulated by the Hog1 MAP kinase \[[@pgen.1008908.ref041]\]. *RHR2*, *GPD2*, and *HGT19* require Sko1 for full expression following osmotic stress \[[@pgen.1008908.ref016]\]. An *rhr2Δ/Δ* mutant strain is sensitive to cationic stress \[[@pgen.1008908.ref028]\], and heterologous expression of *C*. *albicans ENA21* in *Candida dubliniensis* suppresses a hyperosmotic growth defect \[[@pgen.1008908.ref042]\].

*ENA21*, *GPD2*, *RHR2*, *SOU1*, and several *HGT* family members are significantly modulated in response to caspofungin stress. Sko1 and Cas5 partially regulate *GPD2* and *RHR2* \[[@pgen.1008908.ref006], [@pgen.1008908.ref008]\]. However, our ChIP-seq data demonstrates that Sko1 directly regulates *YPD1*, *HGT19*, *ENA21*, and *SOU1*. Although we previously identified *GPD2* and *RHR2* as caspofungin-induced Sko1 targets from microarray experiments \[[@pgen.1008908.ref006]\], the failure to identify additional osmotic stress-responsive genes in that prior study led us to conclude that Sko1 was not involved in coordinating the osmotic stress response generated by caspofungin treatment. Our identification of additional osmotic stress hallmark genes and HOG pathway regulators as direct Sko1 target genes in this study, however, establishes that a specific aspect of caspofungin-induced Sko1 signaling is indeed to regulate the response to osmotic stress.

*YPD1* and *PTP2* inhibit HOG pathway signaling \[[@pgen.1008908.ref043]--[@pgen.1008908.ref045]\]. In *S*. *cerevisiae*, Sko1 increases *PTP2* expression following osmotic stress in order to control Hog1 \[[@pgen.1008908.ref046]\]. We previously demonstrated that Hog1 does not regulate Sko1 following caspofungin stress but instead, phosphorylates Sko1 in response to NaCl stress \[[@pgen.1008908.ref006]\]. Our results show increased Sko1 upstream intergenic region enrichment of *YPD1* and *PTP2* following caspofungin treatment. This finding suggests that Sko1 may inhibit Hog1 activity following cell wall stress. Interestingly, our results also show that Sko1 occupies its own upstream intergenic region ([Fig 4G](#pgen.1008908.g004){ref-type="fig"}). This observation demonstrates that Sko1 likely regulates its own transcription following cell wall stress. We propose that self-regulation and inhibition of HOG pathway signaling may allow Sko1 to regulate osmotic stress response genes independently following caspofungin-induced cell wall stress.

Extension of Sko1 cell wall related functions {#sec013}
---------------------------------------------

Our ChIP-seq findings revealed new direct Sko1 target genes with functions in cell wall integrity, including *PGA56*, *PGA59*, *PGA62*, *PHR2*, and the chaperone *SSA2* ([S2 Table](#pgen.1008908.s002){ref-type="supplementary-material"}). In a prior microarray study, Sko1 was found to modulate the expression of 11 cell wall genes in response to caspofungin treatment including *CRH11*, *PGA13*, and *PHR1* \[[@pgen.1008908.ref006]\]. However, only one of these genes, *PGA31*, was identified as a direct Sko1 target gene in the current study. Taken together, these findings indicate that most Sko1-dependent cell wall integrity genes are indirectly regulated. We identified four transcription factor-encoding genes as direct Sko1 targets: *NRG1*, *EFG1*, *AHR1*, and *TCC1*. It is possible that these regulators work in concert with Sko1 to modulate CWD signaling. Chaperone function is essential for the cell wall adaptive response; for example, Hsp90 mediates caspofungin tolerance by modulating the PKC-MAPK pathway \[[@pgen.1008908.ref047]\]. However, the role of Ssa2 in the CWD response is unknown. Collectively, our ChIP-seq results and previous microarray findings extend our understanding of Sko1 control of cell wall integrity genes.

Our results also implicate a new role for Sko1 in cellular aggregation. We identified the transcriptional regulators, *EFG1* and *NRG1*, and the adhesin, *ALS1*, as Sko1 direct target genes ([Fig 4A](#pgen.1008908.g004){ref-type="fig"} and [S2 Appendix](#pgen.1008908.s007){ref-type="supplementary-material"}). Cellular aggregation is significantly increased following caspofungin treatment and is dependent on Als1 and Efg1 \[[@pgen.1008908.ref048], [@pgen.1008908.ref049]\], although the physiological basis of this behavior is unclear. Nevertheless, an *efg1Δ/Δ* mutant strain is hypersensitive to caspofungin and fails to upregulate *ALS1* \[[@pgen.1008908.ref049]\]. The PKA-MAPK pathway regulates Efg1 in morphogenesis and biofilm formation but does not seem to play a role in the response to caspofungin treatment \[[@pgen.1008908.ref049]\]. While a *sko1Δ/Δ* mutant strain does not have a defect in cellular adhesion and aggregation \[[@pgen.1008908.ref050]\], Efg1 regulates multiple diverse processes, so it is likely that other regulators may indirectly control Efg1 activity in CWD signaling. Our findings reveal that Sko1 may play a role in caspofungin-induced Efg1/Als1-mediated cellular aggregation.

Contribution of glycerol to cell wall stress adaptation {#sec014}
-------------------------------------------------------

Our growth assay results indicate that overproduction of glycerol can partially suppress caspofungin hypersensitivity in a *sko1Δ/Δ* mutant strain ([Fig 6A](#pgen.1008908.g006){ref-type="fig"}). Glycerol functions as a molecular protectant during hyperosmotic stress by replacing water as an intracellular solute and by maintaining turgor \[[@pgen.1008908.ref027]\]. Also, glycerol is required to generate turgor during biofilm development and regulates the expression of several cell wall adhesin proteins including Als1 \[[@pgen.1008908.ref051]\]. This finding strongly suggests that caspofungin hypersensitivity in the *sko1Δ/Δ* mutant strain is caused, in part, by the inability to counteract osmotic stress.

On the other hand, glycerol overproduction did not suppress caspofungin hypersensitivity in the *rlm1Δ/Δ* mutant strain ([Fig 6B](#pgen.1008908.g006){ref-type="fig"}). This observation was surprising since *SKO1* overexpression partially suppressed this phenotype ([Fig 5](#pgen.1008908.g005){ref-type="fig"}). Also, *rlm1Δ/Δ* mutant strains survive when grown on caspofungin medium containing 1.0 M sorbitol \[[@pgen.1008908.ref012]\]. Therefore, other factors must contribute to caspofungin hypersensitivity in the *rlm1Δ/Δ* mutant strain. Our ChIP-seq results identified *PGA59*, *PGA62*, and *PHR2* as Rlm1 and Sko1 direct target genes, although we note that *PGA59* is bound by Rlm1 in both the presence and absence of caspofungin. We propose that *SKO1* overexpression suppresses caspofungin hypersensitivity in the *rlm1Δ/Δ* mutant strain by upregulating cell wall integrity genes.

Conclusions {#sec015}
-----------

This study addressed four mechanistic aspects underlying the Sko1 and Rlm1 transcriptional response to caspofungin-induced cell wall signaling. (i) Sko1 and Rlm1 work cooperatively to regulate distinct gene classes whose functions include osmoregulation, adhesion, secretion, and glucose sensing. (ii) Sko1 specifically mediates the response to caspofungin-induced osmotic stress independently of HOG pathway signaling, Rlm1, and Cas5. (iii) *SKO1* caspofungin-induced transcription occurs via self-regulation, and (iv) glycerol accumulation can partially suppresses caspofungin hypersensitivity.

A key issue that remains unresolved is the mechanism through which Rlm1 activates Sko1 signaling. Our findings clearly demonstrate that this action occurs at the post-translational level. One hypothesis is that CWD-induced carbohydrate flux promotes increased nuclear accumulation of Sko1. In this context, we propose that *SHA3* and *HGT19* may promote Sko1 signaling. In *S*. *cerevisiae*, the Sha3 ortholog, Sks1, phosphorylates the Hgt19 ortholog, Itr1, to mediate glucose metabolism \[[@pgen.1008908.ref039]\]. However, it is unknown if this interaction influences Sko1 activity. Exploring Sko1 function and localization in *sha3Δ/Δ* and *hgt19Δ/Δ* mutant strains would shed light on this idea.

Methods {#sec016}
=======

Yeast strains and media {#sec017}
-----------------------

All *C*. *albicans* strains used in this study were derived from the wild-type reference strain BWP17 (*ura3*Δ::λ*imm434/ura3*Δ::λ*imm434*, *arg4*::*hisG/arg4*::*hisG*, *his1*::*hisG/his1*::*hisG*) or its derivative strains DAY185 and DAY286 \[[@pgen.1008908.ref052], [@pgen.1008908.ref053]\]. All strains used in experimental assays were isogenic, and genotypes are listed in [S1 Table](#pgen.1008908.s001){ref-type="supplementary-material"} ([S1 Table](#pgen.1008908.s001){ref-type="supplementary-material"}). Cultures were prepared in YPD^uri^ (1% yeast extract, 2% peptone, 2% dextrose, 80 mg/L uridine) media at 30°C with shaking at 225 rpm unless otherwise noted.

Construction of yeast strains {#sec018}
-----------------------------

Overexpressing and epitope-tagged strains were constructed by PCR-mediated homologous recombination \[[@pgen.1008908.ref052]\]. Oligonucleotide sequences are listed in [S1 Table](#pgen.1008908.s001){ref-type="supplementary-material"}. Yeast transformations followed the lithium acetate protocol and all constructed strains were verified by colony PCR \[[@pgen.1008908.ref054]\]. We created plasmid pCJN613 as a template to produce an amplicon containing V5-specific sequences. This plasmid contains the V5 epitope tag sequence from the pYES2.1/V5-His-TOPO vector (Invitrogen) and the nourseothricin resistance gene (*NAT*) sequence from plasmid pCJN542 \[[@pgen.1008908.ref055]\]. The *RLM1-V5* amplicon was transformed into *C*. *albicans* strain DAY185 and integrated directly following the final *RLM1* amino acid-encoding codon to produce strain JMR228.

To construct the *P*~*TDH3*~*SKO1* and *P*~*TDH3*~*SKO1-rlm1Δ/Δ* overexpressing strains JMR171 and JMR213, we used pCJN542 as a template to produce an amplicon containing the glyceraldehyde-3-phosphate dehydrogenase *(TDH3*) promoter sequences, NAT resistance gene, and *SKO1*-specific sequences. The amplicon was transformed into the *C*. *albicans* wild-type strain (DAY185) or *rlm1Δ/Δ* mutant strain (VIC1090) and integrated directly upstream of the *SKO1* start codon.

To construct the *P*~*TDH3*~*RHR2-sko1Δ/Δ* and *P*~*TDH3*~*RHR2-rlm1Δ/Δ* overexpressing strains, JMR155 and SF001, we amplified the *TDH3* promoter and *NAT* resistance gene as described above. The amplicon was transformed into the *sko1Δ/Δ* mutant strain (JMR104) or *rlm1Δ/Δ* mutant strain (VIC1090) and integrated directly upstream of the *RHR2* start codon.

Real-time-qPCR (RT-qPCR) assays {#sec019}
-------------------------------

RT-qPCR reactions were performed as previously described \[[@pgen.1008908.ref016]\]. Briefly, RNA was purified from log phase wild-type and *rlm1Δ*/*Δ* mutant cultures treated with or without 125 ng/mL caspofungin for 30 minutes using the RiboPure yeast kit (Ambion). cDNA was synthesized using the AffinityScript Multiple Temperature cDNA Synthesis Kit (Agilent Technologies) following the manufacturer's instructions. RT-qPCR reactions were prepared in triplicate and carried out at least twice using independently prepared yeast cultures. Gene expression changes were calculated using the ΔΔC~T~ method \[[@pgen.1008908.ref056]\]. Target gene fold changes for caspofungin-treated or untreated control groups were determined by comparison to the wild-type strain, and significant differences between groups were determined using unpaired t-tests.

Genome-wide chromatin immunoprecipitation followed by sequencing (ChIP-seq) {#sec020}
---------------------------------------------------------------------------

We used the *SKO1-V5*, *RLM1-V5*, and isogenic wild-type reference strains for chromatin immunoprecipitation. Three independent samples were grown, processed, and sequenced for the tagged (experimental) and untagged (control) strains in the presence or absence of caspofungin. Samples for ChIP-seq were harvested and processed as follows. Overnight cultures were diluted to an OD~600nm~ of 0.2 in 200 mL of fresh YPD^uri^ and grown to an OD~600nm~ between 0.8 to 1.0. Next, cultures were split into two, and one set of cultures was exposed to 125 ng/mL of caspofungin for 30 minutes at 30˚C with shaking at 225 rpm. After 30 minutes, cells were harvested and processed for immunoprecipitation as described previously \[[@pgen.1008908.ref057]\]. Briefly, crosslinking was performed for 15 min with formaldehyde. The crosslinks were quenched with glycine, and cells were lysed with glass beads using a Ribolyser sample homogenizer (Thermo Fisher). Chromatin was sheared into \~300 bp fragments by sonication using a Bioruptor (Diagenode). For each ChIP sample, immunoprecipitation was performed with 2 μg anti-V5 antibodies (Invitrogen) in a final volume of 500 μL with Protein A-Sepharose 4 Fast Flow beads (GE Healthcare). Following protease treatment and crosslinking reversal, samples were purified with phenol: chloroform and ethanol, air-dried and stored at -20˚C.

Library preparation and sequencing {#sec021}
----------------------------------

Library construction from reverse-crosslinked chromatin immunoprecipitated samples and DNA sequencing were performed by the DNA Technologies and Expression Analysis genome sequencing laboratory at the University of California, Davis. The Hyper DNA Library Prep Kit (KAPA) was used for library construction, and after size selection, samples were pooled and sequenced (40 bp, paired-end reads) using an Illumina NextSeq high-output 75 cycles (Specifications: 330--400 million CPF).

ChIP-seq analysis {#sec022}
-----------------

Illumina paired-end reads were trimmed using Trimmomatic (version 0.38) \[[@pgen.1008908.ref058]\] to remove adapter sequences using the parameters ILLUMINACLIP:2:30:10 and leading or trailing low quality bases in reads with quality scores below 3. This was done while scanning the reads with a 4-base sliding window; reads were trimmed when the average quality dropped below 15. Additionally, read lengths below 36 bps were discarded. Trimmed, paired end reads were then aligned to the reference assembly (version 21) of the *C*. *albicans* genome (strain SC5314) obtained from the Candida Genome Database (CGD) \[[@pgen.1008908.ref019]\]. Reference-based assembly was performed using Bowtie (version 1.2.2) \[[@pgen.1008908.ref059]\], and reads that mapped at most to 3 genomic locations were randomly assigned to one of these loci. Maximum insert size for the paired-end reads was set to 1000. The peaks were visualized, and binding regions identified using MochiView \[[@pgen.1008908.ref060]\] after converting bam files obtained using Bowtie to bigWig and wig formats using deepTools (version 3.3.0) \[[@pgen.1008908.ref061]\].

Consensus motif identification: {#sec023}
-------------------------------

Peaks corresponding to Sko1 and Rlm1 binding events were identified and 500 bp regions extracted and centered around the identified peaks. The top 25% highly enriched peaks relative to the untagged control were used to identify the Sko1 consensus motif. MEME (version 5.1.1) \[[@pgen.1008908.ref062]\] was used to identify motifs with the maximum width set to 40 bp (the reverse complement strand was also included for the motif search). The motifs obtained from MEME were corroborated with the motifs obtained using the motif finder function in MochiView \[[@pgen.1008908.ref060]\]. Since fewer binding events were identified for Rlm1, the top 50% of highly enriched peaks relative to the untagged control were used to identify the Rlm1 consensus motif.

Functional enrichment of target genes: {#sec024}
--------------------------------------

Cluster of Orthologous Groups (COG) \[[@pgen.1008908.ref063]\] functional categories were obtained for all target genes of Rlm1 and Sko1 using eggNOG-mapper \[[@pgen.1008908.ref064], [@pgen.1008908.ref065]\]. The percentage of target genes belonging to each functional category was compared to the percentage of all genes in the genome belonging to the same category. Gene Ontology (GO) enrichment \[[@pgen.1008908.ref066]\] was also performed to identify enriched cellular components, biological processes and molecular functions in the target genes. GO terms were annotated through eggNOG-mapper and GO enrichment was performed using the topGO package \[[@pgen.1008908.ref067]\]. To identify enriched GO terms, we used Fisher's exact test with a *P*-value cutoff of 0.01. Enriched KEGG pathways were identified using Pathview \[[@pgen.1008908.ref068], [@pgen.1008908.ref069]\].

Growth assays {#sec025}
-------------

Growth assays on solid and liquid nutrient growth medium were performed as previously described \[[@pgen.1008908.ref070]\]. Briefly, *C*. *albicans* overnight cultures were diluted to a starting OD~600nm~ of 3.0. Cells were serially diluted and spotted onto YPD^uri^ nutrient plates supplemented with 50 ng/mL or 125 ng/mL caspofungin (or without caspofungin as a control) to monitor growth under cell wall stress. Plates were incubated at 30°C and photographed after 24 or 48 hours of growth. To examine growth kinetics under cell wall stress, cells were cultured overnight, standardized to an OD~600nm~ of 0.2 in 200 μL YPD^uri^ in a 96 well plate, and incubated with YPD^uri^ supplemented with 50 ng/mL or 125 ng/mL caspofungin (or water as a control). Samples were grown for 18--24 hours at 30°C with shaking, and OD~600nm~ readings were acquired every 30 minutes using a Synergy Mx plate reader (Biotek).

Supporting information {#sec026}
======================

###### Oligonucleotides and genotypes of strains used in this study.

(XLSX)

###### 

Click here for additional data file.

###### All Rlm1 and Sko1 direct target genes identified via ChIP-seq experiments, as well as GO Enrichment, COG, and *in silico* motif analyses for Rlm1 and Sko1 target gene upstream intergenic regions.

Also included are Sko1 target genes previously identified in caspofungin and osmotic stress microarray experiments.

(XLSX)

###### 

Click here for additional data file.

###### COG analysis of Sko1 and Rlm1 direct target genes.

COG functional categories were determined using eggNOG-mapper for A) Sko1 target genes and B) Rlm1 target genes.

(TIF)

###### 

Click here for additional data file.

###### Verification of the *SKO1* overexpressing strain.

Expression of Sko1 and Rlm1 CWD response genes, *PGA13*, *PGA31*, and *CRH11* was monitored via RT-qPCR analysis in the wild-type strain, *rlm1Δ/Δ* mutant strain and *P*~*TDH3*~*SKO1-rlm1Δ/Δ* overexpressing strain. Gene expression changes were normalized to the caspofungin-treated wild-type strain adjusted to the value of 1.0. Data presented represents the mean of three biological replicates. The single asterisk indicates a *P-*value of ≤ 0.05 between the wild-type and *rlm1Δ/Δ* mutant strains. The double asterisk indicates a *P-*value of ≤ 0.05 between the wild-type and *P*~*TDH3*~*SKO1*-*rlm1Δ/Δ* overexpressing strains.

(TIF)

###### 

Click here for additional data file.

###### KEGG analysis of Sko1 direct target genes.

Sko1 direct target genes are highlighted in red rectangular boxes.

(TIF)

###### 

Click here for additional data file.

###### ChIP-seq MochiView plots of all Rlm1 direct target genes.

Genes are listed in descending order for Rlm1 upstream intergenic region enrichment.

(PDF)

###### 

Click here for additional data file.

###### ChIP-seq MochiView plots of all Sko1 direct target genes.

Genes are listed in descending order for Sko1 upstream intergenic region enrichment.

(PDF)

###### 

Click here for additional data file.
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While revising your submission, please upload your figure files to the [Preflight Analysis and Conversion Engine](http://pace.apexcovantage.com/) (PACE) digital diagnostic tool. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>.

Please be aware that our [data availability policy](http://journals.plos.org/plosgenetics/s/data-availability) requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as \"data not shown\" or \"unpublished results\" in manuscripts. All points should be backed up by data provided with the submission.

PLOS has incorporated [Similarity Check](http://www.crossref.org/crosscheck.html), powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.
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Reviewer\'s Responses to Questions

**Comments to the Authors:**

**Please note here if the review is uploaded as an attachment.**

Reviewer \#1: The manuscript \"An expanded cell wall damage signaling network is comprised of the transcription factors Rlm1 and Sko1 in Candida albicans\" by Heredia et al., describes a link between cell wall damage pathways as well as novel biological roles. The research presented here is significant to the field as it enhances our understanding of the fungal response to antifungal agents, in this case, echinocandins. Additionally, a better understanding of these responses will likely lead to the identification of new drug targets. I am highly enthusiastic about the work presented and do not have significant comments.

Personally, I am interested in the cellular morphology and cell wall composition of the strains used in these studies and think some imaging would be beneficial to the reader and would aid in the understanding of the effect of these pathways on the overall cell structure and response. Additionally, it would be of interest to investigate the role of these pathways in the biofilm lifestyle of C. albicans and in non-albicans species. I also understand that due to the current situation, it is not plausible to acquire new data. This is just a suggestion and does not need to be incorporated unless the authors already have the data.

Reviewer \#2: PGENETICS-D-20-00595; Heredia et al., 'An expanded cell wall damage signaling network is comprised of the transcription factors Rlm1 and Sko1 in Candida albicans'

The authors present an interesting paper on signalling in response to cell wall stress in the human fungal pathogen Candida albicans, focusing on the transcription factors Rlm1 and Sko1. This work first demonstrates that Sko1 appears to be regulated by Rlm1 and contributes to its activity following cell wall damage. The authors then use ChIP-seq experiments in order to identify genes directly controlled by these transcription factors. The results from this work were generally more convincing for Sko1, as Rlm1 binding was only detected for a small number of genes and the peaks identified were generally more subtle. Potential consensus motifs for Rlm1 and Sko1 binding, based on the results from ChIP-seq, were then presented, before finally utilizing suppression analysis to provide further evidence of the link between these two transcription factors.

Key points

Fig 2, L247: The authors demonstrate a fairly constant (\~40%) reduction in expression of Sko1 target genes in the rlm1 mutant. It would have been very useful in the figure to present the expression level of these genes in a sko1 mutant. This would have demonstrated the relative importance of Rlm1 and Sko1 in their regulation, and the interplay of these regulators in their control.

The results of ChIP-seq for Rlm1 only identified a very small set of potential target genes, as such the use of GO enrichment approaches is somewhat questionable. However, this analysis did potentially link Rlm1 function with the spindle pole and trafficking. This result could be discussed in relation to the known role of Slt2 in regulating polarised growth in budding yeast.

In Fig 3 the results presented for Pga59 and Sec10 are unconvincing, with no clear peak. In the discussion of the results it is also important to differentiate between genes that are potentially regulated in response to caspofungin or those that are bound irrespective of its addition. For example, the authors discuss Pga56 alongside Pga59 & Pga62, however, in the case of Pga56 its promoter appears to be bound equally well in the presence or absence of the drug. Finally, the authors identify Pga59 & Pga62 as potential targets, however, the binding site identified is identical in both cases plus appears to be more directly associated with orf19.2766.

The authors state they screened for the presence of the baker's yeast Rlm1 binding motif in the promoter of C. albicans target genes (L257), however, no result of this is presented. Following on from this a highly diverged motif for Rlm1 binding in these two organisms is proposed, the authors could comment on how this fits with the conserved function of Rlm1 between these organisms and the likelihood of conserved targets.

Minor points

Please provide a reference or further information on the pHAS01 vector.

L125: should be 'Sko1-specific sequences'

L:132 should be 'upstream of the RHR2 start codon'.

Fig 1A, L229: Is the increase of Sko1 expression in the cas5 mutant significant?

Fig 1B, L238: Why was elevated expression of Sko1 seen in the complemented rlm1 mutant?

L303: 'Highlighted a new biological role' is an overstatement, without further evidence please refer to as 'potential role'.

L307-325: What is the overlap between the 85 genes bound by Sko1 and the 26 originally described as caspofungin-inducible?

L318: Sko1 binds upstream of its own ORF in response to caspofungin. In addition, it also appears to bind across the ORF irrespective of the presence of caspofungin, the authors could comment on this.

L377 Does the motif for Sko1 identified relate to that previously reported for genes activated or repressed by Sko1?

Fis S2: Please provide stats analysis for Pga13 & Pga31, the same as that presented for Crh11.

Suppl. Table 2, Wksheet 2: For Rlm1 the top 50%, not 25%, enriched proteins were analysed according to the methods section.

Fig S4 L357: PGA13 is only one of multiple genes that could play a role, as such looking at only one potential gene did not really add to the manuscript.

\*\*\*\*\*\*\*\*\*\*
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Large-scale datasets should be made available via a public repository as described in the *PLOS Genetics* [data availability policy](http://journals.plos.org/plosgenetics/s/data-availability), and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.
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Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you've already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at <plosgenetics@plos.org>.
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**Press Queries**

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper\'s publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there\'s anything the journal should know or you\'d like more information, please get in touch via <plosgenetics@plos.org>.
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